Vardenafil and Tamsulosin in the Management of Ureteral Stent-Related Symptoms: A Prospective Comparative Study.

Urol Res Pract · 2025 · PMC12362527 · PMID 40827603

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantP < .001actually significant

Statistically significant differences emerged by the third visit and became highly significant by the fourth visit ( P < .001), favoring vardenafil in all domains except body pain.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.